Your password must be at least 8 characters and contain a number and letter.
(13) Is the New ISHLT Criteria for Pulmonary Antibody-mediated Rejection Also a Severity Indicator?
Hannah Valantine, MD for Adam Cochrane, PharmD
(14) Risk Factors for the Development of Donor-specific Antibodies and Their Impact on Outcomes After Lung TransplantationKevin Tsui, MD
(15) Antibody-mediated Rejection: Should We Wait for Clinical Diagnosis? Sean Agbor-Enoh, MD
(16) Elevated Donor-Derived Cell-Free DNA (ddcfDNA) as an Early Risk Factor for the Development and Persistence of De Novo Donor Specific HLA AntibodyAnnette Jackson, PhD
(17) Important HLA and Non-HLA Pre-Transplant Determinants Associated with the Development of De Novo Donor Specific Antibody After Lung TransplantationAiwen Zhang, PhD
(18) Feasibility of Avoiding Higher Risk Epitope and Allele HLA Mismatch to Reduce de novo Donor Specific Antibody (dnDSA) in Lung Transplantation
Ricardo Zamel, PhD
You must be logged in and own this session in order to